Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Zebra Medical Vision Ltd.. (10/27/17). "Press Release: Zebra Medical Vision to Make AI in Healthcare Accessible & Affordable for All". New York, NY.

Organisations Organisation Zebra Medical Vision Ltd. (Zebra-Med)
  Organisation 2 Khosla Ventures
Products Product AI1 software suite (radiology image analysis)
  Product 2 artificial intelligence (AI) / machine learning (ML)
Persons Person Benjamin, Elad (Zebra Medical Vision 2014– CEO + Co-Founder before Carestream Healthcare Information Solutions)
  Person 2 Stein, Alona (Blonde 2.0 201611 PR Supervisor)

Announcing AI1 - a flat, low fee per scan for all current and future deep learning tools

Zebra Medical Vision, the leading deep learning imaging analytics company, is announcing AI1: a new suite that offers all its current and future algorithms to healthcare providers globally for $1 USD per scan. This is another step in the company’s quest to provide high quality, affordable care to the world’s population. A pioneer in the field of machine and deep learning for medical imaging, Zebra-Med is driving unprecedented transparency in its business model to encourage faster global adoption of advanced tools that can improve health.

Over the last two decades, the demand for imaging services has been increasing, outpacing the supply of qualified physicians, stretching providers and radiologists to constantly produce more output, without compromising patient care. With 2 Billion people expected to join the middle class in the next decade a crisis is imminent. Only by adopting new technology that can significantly enhance the capabilities of radiologists, can this be mitigated. Automated Imaging Analytics tools such as Zebra-med’s Deep Learning engine will provide the needed clinical and computational horsepower to allow radiologists to make the next leap in patient care.

Using millions of longitudinal high quality imaging scans , Zebra-med has been developing a deep learning engine that can automatically detect various medical findings in imaging scans. Current capabilities include automatic detection of liver, lung, cardiovascular and bone disease, and new capabilities are constantly being released – covering breast cancer, lung cancer, brain trauma, hypertension, and other clinical areas. Zebra’s findings are integrated into PACS and RIS systems, allowing radiologists to seamlessly include them in their reading and reporting workflow. This automated assistance contributes to more comprehensive, quantitative and consistent reporting, improving the output of radiologists and contributing to overall improved patient care. The company’s analytics engine is deployed at over 50 hospitals globally, and has analyzed more than 1M patient scans to date.

“With this new model, we hope to facilitate adoption globally, especially in countries where access to radiology is difficult,” says Elad Benjamin, Co-founder and CEO of Zebra Medical Vision. “We are making a commitment to provide our current tools, and all future ones, for a flat $1 USD per scan. By doing so we believe that a true difference can be made in the provision of radiology services worldwide.”

For more information about the availability of the solution in your country or integrating Zebra Medical Vision’s Engine into your hospital or practice, please visit


Zebra Medical Vision uses artificial intelligence and deep learning to create and provide next generation products and services to the healthcare industry. Its Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease, and offer improved, preventative treatment pathways to improve patient care. AI1 is the company’s commitment to make AI-enabled healthcare solutions affordable globally, including its current and future algorithms available for a low flat price per scan. The company has been named a Top 5 global AI company (FastCompany) , Top 50 AI Leader (Fortune) , Cool Vendor (Gartner) and has won the Social Impact Award by Nvidia. Headquartered in Israel, the company was founded in 2014 by Eyal Gura , Eyal Toledano and Elad Benjamin and is funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd, and Dolby Ventures. For more information visit


Elad Benjamin - Co-founder and CEO
Eyal Gura - Co-Founder and Chairman of the Board
Eyal Toledano - Co-Founder and CTO
Social Links

Media Contact

Alona Stein

Record changed: 2021-04-21


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top